2,340 Shares in The Cooper Companies, Inc. (NASDAQ:COO) Acquired by SteelPeak Wealth LLC

SteelPeak Wealth LLC acquired a new stake in The Cooper Companies, Inc. (NASDAQ:COO) in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 2,340 shares of the medical device company’s stock, valued at approximately $237,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of COO. Treasurer of the State of North Carolina boosted its stake in Cooper Companies by 0.9% during the 4th quarter. Treasurer of the State of North Carolina now owns 22,861 shares of the medical device company’s stock valued at $8,652,000 after purchasing an additional 212 shares during the last quarter. Hsbc Holdings PLC boosted its position in shares of Cooper Companies by 55.3% during the fourth quarter. Hsbc Holdings PLC now owns 87,718 shares of the medical device company’s stock valued at $33,188,000 after buying an additional 31,234 shares during the last quarter. Gulf International Bank UK Ltd grew its holdings in Cooper Companies by 300.0% during the first quarter. Gulf International Bank UK Ltd now owns 17,148 shares of the medical device company’s stock worth $1,739,000 after buying an additional 12,861 shares in the last quarter. Parkman Healthcare Partners LLC raised its position in Cooper Companies by 15.1% in the 4th quarter. Parkman Healthcare Partners LLC now owns 75,183 shares of the medical device company’s stock valued at $28,452,000 after buying an additional 9,862 shares during the last quarter. Finally, Czech National Bank lifted its stake in Cooper Companies by 303.2% during the 1st quarter. Czech National Bank now owns 34,968 shares of the medical device company’s stock valued at $3,548,000 after acquiring an additional 26,295 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Down 0.4 %

Shares of NASDAQ COO opened at $87.30 on Monday. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.95 and a quick ratio of 1.14. The stock has a market capitalization of $17.38 billion, a PE ratio of 51.28, a P/E/G ratio of 2.16 and a beta of 0.98. The Cooper Companies, Inc. has a one year low of $75.93 and a one year high of $104.07. The business’s fifty day moving average price is $92.73 and its 200-day moving average price is $94.84.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, May 30th. The medical device company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.83 by $0.02. Cooper Companies had a net margin of 9.11% and a return on equity of 8.87%. The business had revenue of $942.60 million for the quarter, compared to the consensus estimate of $948.07 million. During the same period in the prior year, the firm earned $0.77 earnings per share. The company’s revenue was up 7.4% compared to the same quarter last year. On average, equities research analysts anticipate that The Cooper Companies, Inc. will post 3.57 EPS for the current year.

Wall Street Analyst Weigh In

Several analysts have recently commented on COO shares. Citigroup increased their target price on shares of Cooper Companies from $108.00 to $116.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Robert W. Baird increased their price objective on shares of Cooper Companies from $116.00 to $118.00 and gave the company an “outperform” rating in a research note on Friday, May 31st. Redburn Atlantic upgraded Cooper Companies from a “neutral” rating to a “buy” rating and set a $125.00 target price on the stock in a research note on Tuesday, March 19th. JPMorgan Chase & Co. raised Cooper Companies from a “neutral” rating to an “overweight” rating and increased their price target for the company from $100.00 to $120.00 in a research report on Wednesday, March 13th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a report on Friday, May 31st. Four research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $111.42.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.